LW. Collison, CJ. Workman, TT. Kuo, K. Boyd i inni. The inhibitory cytokine IL-35 contributes to regulatory T-cell function.. „Nature”. 450 (7169), s. 566-9, Nov 2007. DOI: 10.1038/nature06306. PMID: 18033300.
W. Niedbala, XQ. Wei, B. Cai, AJ. Hueber i inni. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells.. „Eur J Immunol”. 37 (11), s. 3021-9, Nov 2007. DOI: 10.1002/eji.200737810. PMID: 17874423.
V. Chaturvedi, LW. Collison, CS. Guy, CJ. Workman i inni. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance.. „J Immunol”. 186 (12), s. 6661-6, Jun 2011. DOI: 10.4049/jimmunol.1100315. PMID: 21576509.
I. Kochetkova, S. Golden, K. Holderness, G. Callis i inni. IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.. „J Immunol”. 184 (12), s. 7144-53, Jun 2010. DOI: 10.4049/jimmunol.0902739. PMID: 20483737.
JQ. Liu, Z. Liu, X. Zhang, Y. Shi i inni. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.. „J Immunol”. 188 (7), s. 3099-106, Apr 2012. DOI: 10.4049/jimmunol.1100106. PMID: 22387555.
GS. Whitehead, RH. Wilson, K. Nakano, LH. Burch i inni. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease.. „J Allergy Clin Immunol”. 129 (1), s. 207-15.e1-5, Jan 2012. DOI: 10.1016/j.jaci.2011.08.009. PMID: 21906794.
H. Mao, W. Gao, C. Ma, J. Sun i inni. Human placental trophoblasts express the immunosuppressive cytokine IL-35.. „Hum Immunol”. 74 (7), s. 872-7, Jul 2013. DOI: 10.1016/j.humimm.2013.04.010. PMID: 23619469.
ZS. Ozkan, M. Simsek, F. Ilhan, D. Deveci i inni. Plasma IL-17, IL-35, interferon-γ, SOCS3 and TGF-β levels in pregnant women with preeclampsia, and their relation with severity of disease.. „J Matern Fetal Neonatal Med”, Dec 2013. DOI: 10.3109/14767058.2013.861415. PMID: 24175856.
K. Guttek, D. Reinhold. Stimulated human peripheral T cells produce high amounts of IL-35 protein in a proliferation-dependent manner.. „Cytokine”. 64 (1), s. 46-50, Oct 2013. DOI: 10.1016/j.cyto.2013.04.037. PMID: 23714111.
M. Seyerl, S. Kirchberger, O. Majdic, J. Seipelt i inni. Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC.. „Eur J Immunol”. 40 (2), s. 321-9, Feb 2010. DOI: 10.1002/eji.200939527. PMID: 19950173.
F. Liu, F. Tong, Y. He, H. Liu. Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients.. „Clin Immunol”. 139 (1), s. 1-5, Apr 2011. DOI: 10.1016/j.clim.2010.12.012. PMID: 21285006.
Z. Wang, JQ. Liu, Z. Liu, R. Shen i inni. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis.. „J Immunol”. 190 (5), s. 2415-23, Mar 2013. DOI: 10.4049/jimmunol.1202535. PMID: 23345334.
H. Guo, W. Wang, N. Zhao, X. He i inni. Inhibiting cardiac allograft rejection with interleukin-35 therapy combined with decitabine treatment in mice.. „Transpl Immunol”. 29 (1-4), s. 99-104, Dec 2013. DOI: 10.1016/j.trim.2013.10.001. PMID: 24103733.
P. Shen, T. Roch, V. Lampropoulou, RA. O'Connor i inni. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.. „Nature”. 507 (7492), s. 366-70, Mar 2014. DOI: 10.1038/nature12979. PMID: 24572363.
RX. Wang, CR. Yu, IM. Dambuza, RM. Mahdi i inni. Interleukin-35 induces regulatory B cells that suppress autoimmune disease.. „Nat Med”, Apr 2014. DOI: 10.1038/nm.3554. PMID: 24743305.
LW. Collison, GM. Delgoffe, CS. Guy, KM. Vignali i inni. The composition and signaling of the IL-35 receptor are unconventional.. „Nat Immunol”. 13 (3), s. 290-9, Mar 2012. DOI: 10.1038/ni.2227. PMID: 22306691.
nih.gov
ncbi.nlm.nih.gov
LW. Collison, CJ. Workman, TT. Kuo, K. Boyd i inni. The inhibitory cytokine IL-35 contributes to regulatory T-cell function.. „Nature”. 450 (7169), s. 566-9, Nov 2007. DOI: 10.1038/nature06306. PMID: 18033300.
W. Niedbala, XQ. Wei, B. Cai, AJ. Hueber i inni. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells.. „Eur J Immunol”. 37 (11), s. 3021-9, Nov 2007. DOI: 10.1002/eji.200737810. PMID: 17874423.
V. Chaturvedi, LW. Collison, CS. Guy, CJ. Workman i inni. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance.. „J Immunol”. 186 (12), s. 6661-6, Jun 2011. DOI: 10.4049/jimmunol.1100315. PMID: 21576509.
I. Kochetkova, S. Golden, K. Holderness, G. Callis i inni. IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.. „J Immunol”. 184 (12), s. 7144-53, Jun 2010. DOI: 10.4049/jimmunol.0902739. PMID: 20483737.
JQ. Liu, Z. Liu, X. Zhang, Y. Shi i inni. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.. „J Immunol”. 188 (7), s. 3099-106, Apr 2012. DOI: 10.4049/jimmunol.1100106. PMID: 22387555.
GS. Whitehead, RH. Wilson, K. Nakano, LH. Burch i inni. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease.. „J Allergy Clin Immunol”. 129 (1), s. 207-15.e1-5, Jan 2012. DOI: 10.1016/j.jaci.2011.08.009. PMID: 21906794.
H. Mao, W. Gao, C. Ma, J. Sun i inni. Human placental trophoblasts express the immunosuppressive cytokine IL-35.. „Hum Immunol”. 74 (7), s. 872-7, Jul 2013. DOI: 10.1016/j.humimm.2013.04.010. PMID: 23619469.
ZS. Ozkan, M. Simsek, F. Ilhan, D. Deveci i inni. Plasma IL-17, IL-35, interferon-γ, SOCS3 and TGF-β levels in pregnant women with preeclampsia, and their relation with severity of disease.. „J Matern Fetal Neonatal Med”, Dec 2013. DOI: 10.3109/14767058.2013.861415. PMID: 24175856.
K. Guttek, D. Reinhold. Stimulated human peripheral T cells produce high amounts of IL-35 protein in a proliferation-dependent manner.. „Cytokine”. 64 (1), s. 46-50, Oct 2013. DOI: 10.1016/j.cyto.2013.04.037. PMID: 23714111.
M. Seyerl, S. Kirchberger, O. Majdic, J. Seipelt i inni. Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC.. „Eur J Immunol”. 40 (2), s. 321-9, Feb 2010. DOI: 10.1002/eji.200939527. PMID: 19950173.
F. Liu, F. Tong, Y. He, H. Liu. Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients.. „Clin Immunol”. 139 (1), s. 1-5, Apr 2011. DOI: 10.1016/j.clim.2010.12.012. PMID: 21285006.
Z. Wang, JQ. Liu, Z. Liu, R. Shen i inni. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis.. „J Immunol”. 190 (5), s. 2415-23, Mar 2013. DOI: 10.4049/jimmunol.1202535. PMID: 23345334.
H. Guo, W. Wang, N. Zhao, X. He i inni. Inhibiting cardiac allograft rejection with interleukin-35 therapy combined with decitabine treatment in mice.. „Transpl Immunol”. 29 (1-4), s. 99-104, Dec 2013. DOI: 10.1016/j.trim.2013.10.001. PMID: 24103733.
P. Shen, T. Roch, V. Lampropoulou, RA. O'Connor i inni. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.. „Nature”. 507 (7492), s. 366-70, Mar 2014. DOI: 10.1038/nature12979. PMID: 24572363.
RX. Wang, CR. Yu, IM. Dambuza, RM. Mahdi i inni. Interleukin-35 induces regulatory B cells that suppress autoimmune disease.. „Nat Med”, Apr 2014. DOI: 10.1038/nm.3554. PMID: 24743305.
LW. Collison, GM. Delgoffe, CS. Guy, KM. Vignali i inni. The composition and signaling of the IL-35 receptor are unconventional.. „Nat Immunol”. 13 (3), s. 290-9, Mar 2012. DOI: 10.1038/ni.2227. PMID: 22306691.
